1. Home
  2. EHTH vs BYSI Comparison

EHTH vs BYSI Comparison

Compare EHTH & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EHTH

eHealth Inc.

HOLD

Current Price

$1.47

Market Cap

52.4M

Sector

Finance

ML Signal

HOLD

Logo BeyondSpring Inc.

BYSI

BeyondSpring Inc.

BUY

Current Price

$1.79

Market Cap

58.4M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
EHTH
BYSI
Founded
1997
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
52.4M
58.4M
IPO Year
2006
2016

Fundamental Metrics

Financial Performance
Metric
EHTH
BYSI
Price
$1.47
$1.79
Analyst Decision
Hold
Analyst Count
3
0
Target Price
$3.33
N/A
AVG Volume (30 Days)
491.6K
14.0K
Earning Date
05-06-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
71.43
N/A
EPS
N/A
N/A
Revenue
$251,395,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$5.60
N/A
P/E Ratio
N/A
N/A
Revenue Growth
45.86
N/A
52 Week Low
$1.20
$1.18
52 Week High
$5.89
$2.50

Technical Indicators

Market Signals
Indicator
EHTH
BYSI
Relative Strength Index (RSI) 40.02 61.79
Support Level $1.43 $1.73
Resistance Level $1.58 $1.83
Average True Range (ATR) 0.14 0.09
MACD -0.02 0.01
Stochastic Oscillator 9.20 95.83

Price Performance

Historical Comparison
EHTH
BYSI

About EHTH eHealth Inc.

eHealth Inc is a company involved in private health insurance marketplace with a technology and service platform that provides consumer engagement, education and health insurance enrollment solutions. The company operates its business in two segments: Medicare which provides health insurance plans and lesser extent ancillary products such as dental and vision insurance and hospital indemnity plans, to medicare eligible consumers; and Employer and Individual provides individual and family health insurance, and small business health insurance plans and Individual Coverage Health Reimbursement Arrangements. It derives maximum revenue from Medicare Segment. All of the company's revenue is derived from the United States. It also has a presence in China.

About BYSI BeyondSpring Inc.

BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin is a novel brain-penetrant microtubule modulator with dendritic cell maturation and vasculature modulation mechanism, which has the potential to help mitigate acquired resistance from prior immune checkpoint inhibitors (ICI) treatment in cancer patients. It is a Selective Immunomodulating Microtubule-Binding Agent (SIMBA), which may provide multiple therapeutic opportunities.

Share on Social Networks: